Henry T. Lynch, M.D., Creighton hereditary
cancer expert, has been selected to receive
a $150,000 award from the Jacqueline
Seroussi Memorial Foundation for Cancer
Research for his research regarding the role
of genetics in pancreatic carcinoma. Dr.
Lynch, professor and chairman of Preventive
Medicine and Public Health, professor of
Medicine, and director of the Hereditary
Cancer Institute at Creighton University
Medical Center, will travel to Tel Aviv to
receive the award on Dec. 4.
The Jacqueline Seroussi Memorial Foundation
for Cancer Research is a non-profit entity
established in Israel by the Ajax Trust to
encourage and reward, on an international
level, research which seeks to prevent and
treat cancer. Dr. Lynch’s award will focus
on the hope of saving the lives of
individuals by studying pancreatic
cancer-prone families.
Dr. Lynch has studied pancreatic cancer and
its hereditary predisposition in certain
families for more than 30 years. Pancreatic
cancer is one of the most deadly cancers,
according to Dr. Lynch. “Hope of conquering
this disease will rest upon a better
understanding of how molecular genetic
research can be used to understand this
cancer’s pathology,” said Dr. Lynch. “One of
my long-term goals is to discover the
reasons why cancer of the pancreas, as well
as breast and colon, occurs in excess in the
Jewish population.”
In addition to this award, Dr. Lynch has
received the Scripps Medal Award,
Bristol-Myers Squibb Award for Distinguished
Achievement in Cancer Research, the American
Association of Cancer Research/American
Cancer Society award for research excellence
in cancer epidemiology and prevention, the
Brinker International Award for Breast
Cancer Research from the Susan G. Komen
Breast Cancer Foundation, and the American
Cancer Society Medal of Honor Award for
research in hereditary cancer and its
clinical translation to patient care.
Earlier this year, Evanston Northwestern
Healthcare Center in Evanston, Ill., named a
Henry T. Lynch M.D. distinguished
lectureship in his honor.
|
|
|
|
Creighton
Hereditary Cancer Expert, Henry T. Lynch, M.D., Receives International
Research Award